The story of Canvaxin, a therapeutic cancer vaccine that showed promise but ultimately failed in clinical trials, and how it paved the way for modern cancer immunotherapy.
Discover how scientists found neoantigen-reactive T cells in relapsing mismatch-repair proficient colorectal cancer, challenging immunotherapy paradigms.
A groundbreaking therapy is teaching immune cells to hunt down one of medicine's most elusive cancers—with astonishing results.
Explore how anti-PD-1 antibodies are transforming cancer treatment by harnessing the body's immune system to fight tumors. Learn about mechanisms, combination therapies, and future directions.
Explore the cutting-edge strategies revolutionizing DNA vaccine performance through molecular engineering, advanced delivery systems, and innovative applications.
Exploring the promising combination of daratumumab and pembrolizumab as immunotherapy for refractory multiple myeloma in a phase 2 clinical trial.
Exploring the revolutionary promise of oncolytic virotherapy for prostate cancer treatment - a precision approach that harnesses viruses to attack cancer cells while awakening immune defenses.
Explore groundbreaking cancer treatments including immunotherapy, CAR-T cell therapy, and precision medicine that are transforming cancer care and improving patient outcomes.
Explore how biotechnology products like monoclonal antibodies and CAR-T cells are revolutionizing cancer treatment through precision medicine and immunotherapy.
Groundbreaking research using one-time gene therapy injection to fight pleural cancers by re-engineering the immune system